| Abbreviation | Full term |
| EC | Endometrial cancer |
| FST | Fertility-sparing treatment |
| G1 | Grade 1 |
| AEH | Atypical endometrial hyperplasia |
| FIGO | International Federation of Gynecology and Obstetrics |
| ESGO | European Society of Gynaecological Oncology |
| ESHRE | European Society of Human Reproduction and Embryology |
| ESGE | European Society for Gynaecological Endoscopy |
| NCCN | National Comprehensive Cancer Network |
| ACOG | American College of Obstetricians and Gynecologists |
| MRI | Magnetic resonance imaging |
| LNG-IUS | Levonorgestrel-releasing intrauterine system |
| MPA | Medroxyprogesterone acetate |
| MA | Megestrol acetate |
| PCOS | Polycystic ovary syndrome |
| GLP-1 | Glucagon-like peptide-1 |
| GLP-1RA | Glucagon-like peptide-1 receptor agonist |
| GIP | Glucose-dependent insulinotropic polypeptide |
| BMI | Body mass index |
| MMRd | Mismatch repair deficiency |
| MSI-H | Microsatellite instability-high |
| POLEmut | POLE exonuclease domain mutation |
| NSMP | No specific molecular profile |
| AH | Atypical hyperplasia |
| EIN | Endometrial intraepithelial neoplasia |
| GnRH-a | Gonadotropin-releasing hormone agonist |
| IGF-1 | Insulin-like growth factor-1 |
| ER | Estrogen receptor |
| PR | Progesterone receptor |
| PGR | Progesterone receptor gene |
| PI3K | Phosphoinositide 3-kinase |
| AKT | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| mTOR | Mechanistic target of rapamycin |
| MAPK | Mitogen-activated protein kinase |
| IL-6 | Interleukin-6 |
| TNF-α | Tumor necrosis factor-α |
| NF-κB | Nuclear factor κB |
| STAT3 | Signal transducer and activator of transcription 3 |
| DHCR24 | 24-Dehydrocholesterol reductase |
| MMR | Mismatch repair |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| CR | Complete response |
| ART | Assisted reproductive technology |
| MDT | Multidisciplinary team |
| RFS | Recurrence-free survival |
| AI | Artificial intelligence |
| AUC | Area under the receiver operating characteristic curve |